GlobalData on MSN21h
CHMP recommends AstraZeneca’s Tagrisso for EU approval for NSCLCThe European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended AstraZeneca's Tagrisso ...
Zacks.com on MSN15h
CHMP Endorses AstraZeneca's Tagrisso for Expanded Use in NSCLCThe CHMP's opinion is based on late-stage data, which show that treatment with AZN's Tagrisso extends progression-free ...
Merck was testing the injectable version of the world's biggest selling drug in a late stage trial of patients with a type of ...
Catumaxomab received a positive opinion from the EMA's Committee for Medicinal Products for Human Use (CHMP) at its October 2024 meeting and if approved catumaxomab will be the only approved drug for ...
We recently compiled a list of the 10 Best German Stocks To Buy Now. In this article, we are going to take a look at where ...
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion ...
AstraZeneca’s Tagrisso (osimertinib) has been recommended for approval in the EU for treating adult patients with ...
In a report released yesterday, Luisa Hector from Berenberg Bank maintained a Buy rating on AstraZeneca (AZN – Research Report), with a price ...
Merck (MRK) declared a quarterly dividend of 81c per share of the company’s common stock for Q1 of 2025. Payment will be made on January 8, ...
The attack came just days after President Biden gave Ukraine permission to use the weapons to strike targets inside Russia. By Marc Santora and Eric Schmitt The envoy, Amos Hochstein, said an ...
Covering Netflix News Independently Since 2013. What’s on Netflix is not owned by or affiliated with Netflix or any of its partners in any capacity. The authors of this site also have no affiliation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback